[{"uuid": "68684e86-4c2f-3c90-bb86-2882d1bbf74d", "title": "Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 90% Above Its Share Price", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/glaukos-corporations-nyse-gkos-intrinsic-114202427.html", "providerPublishTime": 1738323722, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/LmW08w9fc6HkPMfaFL0nbg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "bc5b9151-e808-3e52-a208-cc66bc1c4784", "title": "Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/vanguard-p-small-cap-600-112007537.html", "providerPublishTime": 1738322407, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a", "width": 900, "height": 728, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Qhyx0MmHdHV2_jvK0OQaCg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "564cd5ce-15ae-3dd2-b75d-bdbc4f48e8f3", "title": "Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/spdr-p-600-small-cap-112009448.html", "providerPublishTime": 1737976809, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a", "width": 900, "height": 476, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pdW5wHTIEKqiEK3RrmtVaw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "52ea906e-eac1-3d86-bd6c-53a7934b7681", "title": "Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/glaukos-release-fourth-quarter-full-120000466.html", "providerPublishTime": 1737633600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ihSRHx09QvvPYkykC_XE2g--~B/aD01MTg7dz0yNzc0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/54220f2cbe58b13f92a9ea44ffc92637", "width": 2774, "height": 518, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/QyWszrm7965nQTSOrpGi.Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/54220f2cbe58b13f92a9ea44ffc92637", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "71175664-6a7e-3516-b728-1b665b98b0e3", "title": "Intuitive Surgical, Inc. (ISRG) Q4 Earnings Surpass Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/intuitive-surgical-inc-isrg-q4-221508627.html", "providerPublishTime": 1737670508, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UPInF06X6fJkTqeimnpZuQ--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 900, "height": 745, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tlKVbaKmxwUbiS87UIMwQA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ISRG"]}, {"uuid": "efd4c74b-6ead-3893-bb63-a9acda8968a0", "title": "Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/spdr-p-health-care-equipment-112008314.html", "providerPublishTime": 1737544808, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pDKsOs.OZIPdDtC_zqOnWw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "61af3e2f-edc0-3264-bde3-0200798ab2db", "title": "NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/neuropace-npce-soars-9-1-103200898.html", "providerPublishTime": 1737541920, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/kz0ozt3ejWMPXKci2JxOBw--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9", "width": 1000, "height": 754, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9DuI9CAB81x7COnzMbUTGw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NPCE", "GKOS"]}, {"uuid": "0099addf-7183-343d-a7d6-9a0c1d385423", "title": "GKOS Stock Gains Following Positive Study Data on iDose Platform", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/gkos-stock-gains-following-positive-135100372.html", "providerPublishTime": 1736949060, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/X5f0KWUqd43xLwLZQjf2Jw--~B/aD0zOTI7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 620, "height": 392, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vW_.LtePjTqS..yx9ZX5CQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "0442740a-7aa6-313c-8000-3d7fe83f5762", "title": "Glaukos Announces Positive Clinical Updates for its iDose\u00ae Sustained-Release Procedural Pharmaceutical Platform", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/glaukos-announces-positive-clinical-updates-210500940.html", "providerPublishTime": 1736888700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/K7y9PMDKqv7mHYEzvxwBvw--~B/aD01MTg7dz0yNzc0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7fce0ae82ce561bf315c270fb99b6733", "width": 2774, "height": 518, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/GqvvHsluLua9gohyOdeMyw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7fce0ae82ce561bf315c270fb99b6733", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "ed6311bf-ddbe-3c24-98ae-1efe6810badc", "title": "Here's Why You Should Add Glaukos Stock to Your Portfolio Now", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/heres-why-add-glaukos-stock-124300515.html", "providerPublishTime": 1736426580, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/X5f0KWUqd43xLwLZQjf2Jw--~B/aD0zOTI7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 620, "height": 392, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vW_.LtePjTqS..yx9ZX5CQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS", "RMD", "CAH", "BSX"]}, {"uuid": "a17d1888-02e4-34b1-b92e-1ff3ff6a981c", "title": "Glaukos Reaches 52-Week High: What's Driving the Stock's Rally?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/glaukos-reaches-52-week-high-164500878.html", "providerPublishTime": 1736268300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.gb6XNijFKw.G0R_D0zzsw--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6e7a581172a57923b1e9381146e28fb5", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/KcqVCoZD2hWTS8I4pmfQmQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/6e7a581172a57923b1e9381146e28fb5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS", "RMD", "CAH", "BSX"]}, {"uuid": "385ab690-f216-3c21-9773-cb95b1c7c870", "title": "Glaukos price target raised to $157 from $149 at BTIG", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/glaukos-price-target-raised-157-124509796.html", "providerPublishTime": 1735994709, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/c8pJ6Hc13EFaByQh6DEJ0A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/bircVCqs.PWolEadE6JkKg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "6f925c4f-e5a2-3c0b-9b2d-153a5384aade", "title": "Stifel Adjusts Price Target on Glaukos to $175 From $153, Keeps Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/stifel-adjusts-price-target-glaukos-113822115.html", "providerPublishTime": 1735645102, "type": "STORY", "relatedTickers": ["GKOS"]}, {"uuid": "bd262d0a-e432-35ef-b2a6-4b56d9928735", "title": "Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/glaukos-stock-down-despite-nda-173800415.html", "providerPublishTime": 1735061880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/X5f0KWUqd43xLwLZQjf2Jw--~B/aD0zOTI7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 620, "height": 392, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vW_.LtePjTqS..yx9ZX5CQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS", "ABT"]}, {"uuid": "699a69e6-76eb-3ddb-8da5-a4666a4eaea9", "title": "Glaukos Submits New Drug Application to U.S. FDA for Epioxa\u2122", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/glaukos-submits-drug-application-u-120000301.html", "providerPublishTime": 1734955200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1tcOv4W_MzXsTdNXh02hMA--~B/aD01MTg7dz0yNzc0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/738253fd655b85a9ece8a3687d8c5e8f", "width": 2774, "height": 518, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/A0oQo0Fze6FfWnk0rXZkzA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/738253fd655b85a9ece8a3687d8c5e8f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "2d3d6f0f-cb07-34a0-a3b4-38074268fa58", "title": "Glaukos Insider Sold Shares Worth $498,716, According to a Recent SEC Filing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/glaukos-insider-sold-shares-worth-091845974.html", "providerPublishTime": 1735031925, "type": "STORY", "relatedTickers": ["GKOS"]}, {"uuid": "8d95c397-b679-3707-900e-f24efb66405e", "title": "Glaukos Insider Sold Shares Worth $1,502,800, According to a Recent SEC Filing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/glaukos-insider-sold-shares-worth-091407100.html", "providerPublishTime": 1735031647, "type": "STORY", "relatedTickers": ["GKOS"]}, {"uuid": "df03822b-336d-3ee1-af14-98fcbac2fc8b", "title": "Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/glaukos-stock-soars-77-9-134800382.html", "providerPublishTime": 1732196880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/X5f0KWUqd43xLwLZQjf2Jw--~B/aD0zOTI7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 620, "height": 392, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vW_.LtePjTqS..yx9ZX5CQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "e3affb8a-ebf0-3ab2-af74-aaabf7925a97", "title": "The three-year returns have been stellar for Glaukos (NYSE:GKOS) shareholders despite underlying losses increasing", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/three-returns-stellar-glaukos-nyse-133625729.html", "providerPublishTime": 1734788185, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/LmW08w9fc6HkPMfaFL0nbg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GKOS"]}, {"uuid": "36154abc-5ed0-3436-852f-4e0c6e294670", "title": "Truist Securities Adjusts Price Target on Glaukos to $185 From $152, Keeps Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/truist-securities-adjusts-price-target-144804467.html", "providerPublishTime": 1734533284, "type": "STORY", "relatedTickers": ["GKOS"]}]